Researchers found that the Plasmodiumparasites responsible for malaria rely on human liver cell protein for their development into an infectious form.
Infectious Disease News spoke with Gregory C. Gray, an infectious disease epidemiologist and professor at Duke University, about the status of H7N9 control strategies in China, gaps in control measures, and what else China can do to effectively contain the highly pathogenic avian influenza viruses.
According to newspaper reports, measures include disinfecting farms and restricting sales of pork and processed meat.
A novel dual route vaccination using the Middle East respiratory syndrome coronavirus (MERS-CoV) receptor binding domain sub-unit has been developed.
The US Department of Health and Human Services (HHS) awarded a contract for $535 to Emergent BioSolutions Inc. for Vaccinia Immune Globulin Intravenous (VIGIV) to be used in the Strategic National Stockpile. VIGIV is the only therapeutic licensed by the US Food and Drug Administration (FDA) for the treatment of complications due to smallpox vaccination.
The NanoVax vaccine platform uses a novel oil-in-water emulsion adjuvant that elicits both systemic and mucosal immunity.
Robert Redfield, director of the US Centers for Disease Control and Prevention (CDC), predicted that responders in the Democratic Republic of the Congo will exhaust the current supply of Ebola vaccine before manufacturers can produce more.
The Czech Republic has been the only country to eradicate African swine fever (ASF) during the re-emeging outbreaks around the world in recent years. They eradicated the highly infectious virus through strict control measures, strict biosecurity, and a coordinated approach to both.
One Health is underutilized in the development of vaccines against shared human and animal disease threats.
Southeast Asia is battling to contain the spread of African swine fever, which has so far led to the culling of millions of pigs in China and Vietnam.